Express News | Pfizer Exec Says Co Will Not Comment on Speculation Regarding the Sale of Its Hospital Drugs Unit
Express News | Pfizer (PFE) sues Sandoz, hoping to block the launch of generic drugs for its Inlyta (axitinib, a drug used to treat kidney cell cancer).
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
UBS Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $31
UBS Remains a Hold on Pfizer (PFE)
Express News | Pfizer plans to sell the pharmaceutical department of the hospital, the company's response: no comment.